LGVAX | RMFCX | LGVAX / RMFCX | |
Total Expense Ratio | 1.01 | 0.91 | 111% |
Annual Report Gross Expense Ratio | 1.04 | 0.91 | 114% |
Fund Existence | 17 years | 23 years | - |
Gain YTD | 6.123 | 11.421 | 54% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1000 | 250 | 400% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.9B | 109B | 4% |
Annual Yield % from dividends | 0.75 | 1.24 | 61% |
Returns for 1 year | 1.79 | 7.71 | 23% |
Returns for 3 years | 16.10 | 32.16 | 50% |
Returns for 5 years | 29.66 | 56.41 | 53% |
Returns for 10 years | 70.63 | 91.12 | 78% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HLMIX | 29.16 | 0.28 | +0.97% |
Harding Loevner International Eq Instl | |||
PEGCX | 20.32 | 0.05 | +0.25% |
PGIM Jennison Mid-Cap Growth C | |||
TRGPX | 23.33 | 0.02 | +0.09% |
Nuveen Quant Mid Cap Growth Premier | |||
QMGAX | 12.86 | N/A | N/A |
Invesco Advantage International A | |||
MUXRX | 27.97 | -0.09 | -0.32% |
Victory S&P 500 Index R |